Borrelli A - Search Results

1

Long-term functional end points following middle cerebral artery occlusion in the rat.

Hudzik TJ, Borrelli A, Bialobok P, Widzowski D, Sydserff S, Howell A, Gendron P, Corbett D, Miller J, Palmer GC. Hudzik TJ, et al. Among authors: borrelli a. Pharmacol Biochem Behav. 2000 Mar;65(3):553-62. doi: 10.1016/s0091-3057(99)00243-9. Pharmacol Biochem Behav. 2000. PMID: 10683498

2

Acute heat stress model of seizures in weanling rats: influence of prototypic anti-seizure compounds.

Palmer GC, Borrelli AR, Hudzik TJ, Sparber S. Palmer GC, et al. Among authors: borrelli ar. Epilepsy Res. 1998 May;30(3):203-17. doi: 10.1016/s0920-1211(98)00002-3. Epilepsy Res. 1998. PMID: 9657648

3

[S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties.

Palmer GC, Murray RJ, Cramer CL, Stagnitto ML, Knowles MK, Freedman LR, Eismann MS, Mahmood N, Balestra M, Borrelli AR, Hudzik TJ, McCarthy DJ. Palmer GC, et al. Among authors: borrelli ar. J Pharmacol Exp Ther. 1999 Jan;288(1):121-32. J Pharmacol Exp Ther. 1999. PMID: 9862762

4

Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia.

Palmer GC, Cregan EC, Borrelli AR, Harris EW, Stagnitto ML, Colombo P, Kaiser FC, Murray RJ, Griffith RC, Strand JC. Palmer GC, et al. Among authors: borrelli ar. J Pharmacol Exp Ther. 1995 Aug;274(2):991-1000. J Pharmacol Exp Ther. 1995. PMID: 7636764

5

Neuroprotective properties of the uncompetitive NMDA receptor antagonist remacemide hydrochloride.

Palmer GC, Cregan EF, Borrelli AR, Willett F. Palmer GC, et al. Among authors: borrelli ar. Ann N Y Acad Sci. 1995 Sep 15;765:236-47; discussion 248. doi: 10.1111/j.1749-6632.1995.tb16580.x. Ann N Y Acad Sci. 1995. PMID: 7486610 Review. No abstract available.

6

Flavodilol: a new antihypertensive agent.

Kinsolving CR, Watkins BE, Borrelli AR, Kaiser FC, Wu ES. Kinsolving CR, et al. Among authors: borrelli ar. J Cardiovasc Pharmacol. 1989 Jul;14(1):127-41. J Cardiovasc Pharmacol. 1989. PMID: 2475704

7

Interaction studies with metolazone, heparin and protamine sulfate.

Yelnosky J, Borrelli A, Kaiser F, Belair E. Yelnosky J, et al. Among authors: borrelli a. Arch Int Pharmacodyn Ther. 1973 Jul;204(1):5-11. Arch Int Pharmacodyn Ther. 1973. PMID: 4746632 No abstract available.

8

Interaction studies with metolazone, ouabain and lidocaine.

Yelnosky J, Borrelli A, Kaiser F, Belair E. Yelnosky J, et al. Among authors: borrelli a. Arch Int Pharmacodyn Ther. 1972 May;197(1):93-101. Arch Int Pharmacodyn Ther. 1972. PMID: 5031582 No abstract available.

9

Flavones. 2. Synthesis and structure-activity relationship of flavodilol and its analogues, a novel class of antihypertensive agents with catecholamine depleting properties.

Wu ES, Cole TE, Davidson TA, Dailey MA, Doring KG, Fedorchuk M, Loch JT 3rd, Thomas TL, Blosser JC, Borrelli AR, et al. Wu ES, et al. Among authors: borrelli ar. J Med Chem. 1989 Jan;32(1):183-92. doi: 10.1021/jm00121a034. J Med Chem. 1989. PMID: 2909730

10

Flavones. 1. Synthesis and antihypertensive activity of (3-phenylflavonoxy)propanolamines without beta-adrenoceptor antagonism.

Wu ES, Cole TE, Davidson TA, Blosser JC, Borrelli AR, Kinsolving CR, Milgate TE, Parker RB. Wu ES, et al. Among authors: borrelli ar. J Med Chem. 1987 May;30(5):788-92. doi: 10.1021/jm00388a007. J Med Chem. 1987. PMID: 2883317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters